235 related articles for article (PubMed ID: 22430205)
1. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.
Zhou C; Licciulli S; Avila JL; Cho M; Troutman S; Jiang P; Kossenkov AV; Showe LC; Liu Q; Vachani A; Albelda SM; Kissil JL
Oncogene; 2013 Feb; 32(7):903-9. PubMed ID: 22430205
[TBL] [Abstract][Full Text] [Related]
2. Requirement for Rac1 in a K-ras induced lung cancer in the mouse.
Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T
Cancer Res; 2007 Sep; 67(17):8089-94. PubMed ID: 17804720
[TBL] [Abstract][Full Text] [Related]
3. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.
Seiz JR; Klinke J; Scharlibbe L; Lohfink D; Heipel M; Ungefroren H; Giehl K; Menke A
Biol Chem; 2020 Mar; 401(4):517-531. PubMed ID: 31811797
[TBL] [Abstract][Full Text] [Related]
4. K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity.
Samuel MS; Lourenço FC; Olson MF
PLoS One; 2011 Feb; 6(2):e17143. PubMed ID: 21358804
[TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL
Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.
Stallings-Mann ML; Waldmann J; Zhang Y; Miller E; Gauthier ML; Visscher DW; Downey GP; Radisky ES; Fields AP; Radisky DC
Sci Transl Med; 2012 Jul; 4(142):142ra95. PubMed ID: 22786680
[TBL] [Abstract][Full Text] [Related]
7. GTPase splice variants RAC1 and RAC1B display isoform-specific differences in localization, prenylation, and interaction with the chaperone protein SmgGDS.
Koehn OJ; Lorimer E; Unger B; Harris R; Das AS; Suazo KF; Auger SA; Distefano MD; Prokop JW; Williams CL
J Biol Chem; 2023 Jun; 299(6):104698. PubMed ID: 37059183
[TBL] [Abstract][Full Text] [Related]
8. PKC
Garg R; Cooke M; Benavides F; Abba MC; Cicchini M; Feldser DM; Kazanietz MG
Cancer Res; 2020 Dec; 80(23):5166-5173. PubMed ID: 32994205
[TBL] [Abstract][Full Text] [Related]
9. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen inhibits colitis-induced overexpression of tumor-related Rac1b.
Matos P; Kotelevets L; Goncalves V; Henriques AF; Henriques A; Zerbib P; Moyer MP; Chastre E; Jordan P
Neoplasia; 2013 Jan; 15(1):102-11. PubMed ID: 23359345
[TBL] [Abstract][Full Text] [Related]
11. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.
Mehner C; Miller E; Khauv D; Nassar A; Oberg AL; Bamlet WR; Zhang L; Waldmann J; Radisky ES; Crawford HC; Radisky DC
Mol Cancer Res; 2014 Oct; 12(10):1430-9. PubMed ID: 24850902
[TBL] [Abstract][Full Text] [Related]
13. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
Justilien V; Fields AP
Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
[TBL] [Abstract][Full Text] [Related]
14. The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.
Kotelevets L; Walker F; Mamadou G; Lehy T; Jordan P; Chastre E
Oncogene; 2018 Nov; 37(46):6054-6068. PubMed ID: 29985482
[TBL] [Abstract][Full Text] [Related]
15. RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy.
Alonso-Espinaco V; Cuatrecasas M; Alonso V; Escudero P; Marmol M; Horndler C; Ortego J; Gallego R; Codony-Servat J; Garcia-Albeniz X; Jares P; Castells A; Lozano JJ; Rosell R; Maurel J
Eur J Cancer; 2014 Jul; 50(11):1973-81. PubMed ID: 24833563
[TBL] [Abstract][Full Text] [Related]
16. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
[TBL] [Abstract][Full Text] [Related]
17. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation.
Singh A; Karnoub AE; Palmby TR; Lengyel E; Sondek J; Der CJ
Oncogene; 2004 Dec; 23(58):9369-80. PubMed ID: 15516977
[TBL] [Abstract][Full Text] [Related]
18. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.
Justilien V; Jameison L; Der CJ; Rossman KL; Fields AP
J Biol Chem; 2011 Mar; 286(10):8149-8157. PubMed ID: 21189248
[TBL] [Abstract][Full Text] [Related]
20. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process.
Visvikis O; Lorès P; Boyer L; Chardin P; Lemichez E; Gacon G
FEBS J; 2008 Jan; 275(2):386-96. PubMed ID: 18093184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
